You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
《公司業績》華潤醫藥(03320.HK)全年純利近33億元微升0.3% 末期息增至12仙
阿思達克 03-26 12:10
華潤醫藥(03320.HK)公布截至去年12月底止全年業績,營業額2,004.23億元,按年跌2%。純利32.97億元,按年微升0.3%;每股盈利0.52元。派末期息0.12元,對上財年同期派0.11元。

期內集團毛利錄322.94億元,按年減少5.1%,整體毛利率為16.1%,按年下降0.5個百分點,主要由於期內製藥業務平均毛利率有所下降,以及毛利率相對高的製藥業務收益佔比下降所致。

按業務劃分,製藥業務實現分部收入因受疫情及帶量採購疊加影響,按年下跌4.7%至322.07億元;醫藥分銷分銷業務實現分部收入1,688.32億元,按年減少1.1%;醫藥零售業務收入則按年微升0.1%至64.67億元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account